HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons [Phase 1]
This update notes the completion of a Phase I clinical trial evaluating the HIV-1 C4-V3 polyvalent peptide vaccine in HIV-infected individua…
-
FDA approval · 2013-05-03FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for STRIBILD (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) from Gilea…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking [Phase 3]
Phase 3 clinical trial update reporting the completion of a study evaluating strategies to motivate HIV-positive Latinos to quit smoking. Th…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: HIV Prevention With the Mentally Ill [Phase 2]
Phase 2 trial evaluating HIV prevention in people with mental illness has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Mentor Mothers: A Sustainable Family Intervention in South African Townships [Phase 2]
Phase 2 trial update on Mentor Mothers, a sustainable family intervention in South African townships, addressing HIV/AIDS with related condi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-05-01Clinical Trial Update: Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation
A completed research study investigating how adolescent women perceive HIV risk and what factors influence participation in microbicide tria…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy [NA]
This clinical trial update assesses the efficacy and safety of a first-line antiretroviral regimen—tenofovir disoproxil fumarate, lamivudine…
-
CLINICAL_TRIALS research · 2013-05-01Clinical Trial Update: Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection [NA]
An update on a raltegravir-based antiretroviral therapy trial for resistant HIV-1 infection; the phase and current trial status are not spec…
-
FDA approval · 2013-04-30FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
The FDA approved a supplemental application for etravirine (ETRAVIRINE) submitted by Patriot Pharmaceuticals. The action pertains to an HIV-…
-
CLINICAL_TRIALS trial_result · 2013-04-30Clinical Trial Update: Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects [Phase 4]
Phase 4 study evaluating maraviroc in immunological non-responders among HIV-1-infected subjects has completed.
-
CLINICAL_TRIALS withdrawal · 2013-04-30Clinical Trial Update: Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women
The study examining how the menstrual cycle influences antiretroviral pharmacokinetics in HIV-infected women has been withdrawn from clinica…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: The Effects of Nutritional Supplementation and Drug Abuse on HIV [NA]
This clinical trial evaluated the effects of nutritional supplementation and drug abuse on HIV patients; the study has completed.
-
FDA approval · 2013-04-26FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for EDURANT (rilpivirine hydrochloride) submitted by Janssen Products, LP.
-
FDA approval · 2013-04-24FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for Prezista (darunavir) from Janssen Products LP.
-
FDA approval · 2013-04-24FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP.
-
CLINICAL_TRIALS research · 2013-04-22Clinical Trial Update: A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects [Phase 1]
Phase 1 study evaluating the effect of calcium carbonate and ferrous fumarate on the pharmacokinetics of dolutegravir in healthy adult subje…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)
This clinical trial update reports results from a completed study evaluating once-daily Kaletra (lopinavir/ritonavir) for HIV infection, wit…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir [Phase 1]
Phase 1 study examining pharmacokinetic interactions between telaprevir and un-boosted atazanavir in adults with chronic hepatitis C and HIV…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Genotype Based Personalized Prescription of Nevirapine [Phase 4]
A Phase 4 clinical trial evaluating genotype-based personalized prescribing of nevirapine has completed, examining nevirapine-induced rash a…
-
FDA approval · 2013-04-19FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) from …
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR [Phase 2]
A Phase 2 study assessed switching from the efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen to the emtricitabine…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF [Phase 3]
A Phase 3 trial evaluating switching HIV-1 patients from ritonavir-boosted protease inhibitor regimens with two NRTIs to a fixed-dose tablet…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Safety Study of UC-781 Vaginal Microbicide [Phase 1]
A Phase 1 safety study of UC-781 vaginal microbicide for HIV prevention has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV [NA]
This clinical trial update describes a study of Modified Directly Observed Therapy to improve adherence to antiretroviral therapy in people …
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: A Network & Dyad HIV Prevention Intervention for IDU's - 1 [Phase 2]
Phase 2 results posted for a network and dyad HIV prevention intervention targeting injection drug users; the study is completed and results…